Compounds > platinum
Page last updated: 2024-08-22

platinum and Carcinoma, Lewis Lung

platinum has been researched along with Carcinoma, Lewis Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benetollo, F; Bertani, R; Colavito, D; Del Giudice, E; Gandin, V; Marzano, C; Mazzega Sbovata, S; Michelin, RA; Schiavon, M; Seraglia, R; Venzo, A1
Amarasiriwardena, C; Basu, S; Bonventre, JV; Chin, KT; Connor, Y; Dinulescu, DM; Jayawardene, I; Kopparam, J; Kulkarni, A; Lupoli, N; Mashelkar, RA; Muto, K; Oh, MS; Pandey, A; Paraskar, AS; Roy, B; Sabbisetti, VS; Sarangi, S; Sengupta, P; Sengupta, S; Soni, S1
Dupuis, NP; Emi, Y; Goff, DA; Robinson, MF; Teicher, BA1
Bergman, AM; Kuiper, CM; Peters, GJ; Pinedo, HM; van der Vijgh, WJ; van Moorsel, CJ; Veerman, G; Vermorken, JB1

Other Studies

4 other study(ies) available for platinum and Carcinoma, Lewis Lung

ArticleYear
A new class of antitumor trans-amine-amidine-Pt(II) cationic complexes: influence of chemical structure and solvent on in vitro and in vivo tumor cell proliferation.
    Journal of medicinal chemistry, 2010, Aug-26, Volume: 53, Issue:16

    Topics: Amidines; Amines; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Lewis Lung; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; Crystallography, X-Ray; DNA Damage; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Mice; Mice, Inbred BALB C; Platinum; Solubility; Stereoisomerism; Structure-Activity Relationship; Tumor Suppressor Protein p53

2010
Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Jul-10, Volume: 109, Issue:28

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Survival; Cholesterol; Cisplatin; Drug Carriers; Drug Delivery Systems; Drug Screening Assays, Antitumor; Inhibitory Concentration 50; Kidney; Mice; Models, Chemical; Nanoparticles; Nanotechnology; Platinum; Succinic Acid

2012
Antiangiogenic treatment (TNP-470/minocycline) increases tissue levels of anticancer drugs in mice bearing Lewis lung carcinoma.
    Oncology research, 1995, Volume: 7, Issue:5

    Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Carmustine; Cell Hypoxia; Cell Survival; Cisplatin; Cyclohexanes; Cyclophosphamide; DNA, Neoplasm; Drug Combinations; Male; Melphalan; Mice; Mice, Inbred C57BL; Minocycline; O-(Chloroacetylcarbamoyl)fumagillol; Platinum; Sesquiterpenes; Tumor Cells, Cultured

1995
Mechanisms of synergism between cisplatin and gemcitabine in ovarian and non-small-cell lung cancer cell lines.
    British journal of cancer, 1999, Volume: 80, Issue:7

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Cell Division; Cisplatin; Deoxycytidine; DNA; DNA Adducts; DNA Damage; Dose-Response Relationship, Drug; Drug Synergism; Female; Fluorometry; Gemcitabine; Humans; Intracellular Fluid; Lung Neoplasms; Mice; Ovarian Neoplasms; Platinum; RNA; Time Factors; Tumor Cells, Cultured; Tumor Stem Cell Assay

1999